Free Trial

Maze Therapeutics (MAZE) Earnings Date, Estimates & Call Transcripts

Maze Therapeutics logo
$26.46 -0.10 (-0.36%)
Closing price 03:59 PM Eastern
Extended Trading
$26.48 +0.02 (+0.08%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Maze Therapeutics Earnings Summary

Maze Therapeutics released Q4 2025 earnings on March 25, 2026, reporting an EPS of -$0.65, which topped the consensus estimate of -$0.73 by $0.08. With a trailing EPS of -$3.23, Maze Therapeutics' earnings are expected to decrease next year, from ($2.59) to ($3.11) per share.

Consensus EPS
(Mar. 25)
-$0.73
Actual EPS
(Mar. 25)
-$0.65 Beat By $0.08

Q4 2025 Earnings Resources

Get Maze Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Maze Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

MAZE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Maze Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$0.82-$0.53-$0.72
Q2 20263-$0.82-$0.57-$0.69
Q3 20263-$0.82-$0.54-$0.68
Q4 20263-$0.82-$0.56-$0.69

Maze Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/25/2026Q4 2025-$0.73-$0.65+$0.08-$0.65--
11/6/2025Q3 2025-$0.74-$0.66+$0.08-$0.66--
8/12/2025Q2 2025-$0.79-$0.77+$0.02-$0.77$12.50M-
5/14/2025Q1 2025-$0.76-$1.15 -$0.39-$1.15--
3/31/2025--$7.60-$18.32 -$10.72-$18.32--

Data powered by Fiscal.ai.

Maze Therapeutics Earnings - Frequently Asked Questions

Maze Therapeutics (NASDAQ:MAZE) last announced its quarterly earning data on Wednesday, March 25, 2026. Learn more on MAZE's earnings history.

In the previous quarter, Maze Therapeutics (NASDAQ:MAZE) reported ($0.65) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.73) by $0.08. Learn more on analysts' earnings estimate vs. MAZE's actual earnings.

Maze Therapeutics (NASDAQ:MAZE) has a recorded annual revenue of $167.50 million.

Maze Therapeutics (NASDAQ:MAZE) has a recorded net income of -$131.12 million. MAZE has generated -$3.23 earnings per share over the last four quarters.

Maze Therapeutics' earnings are expected to decrease from ($2.59) per share to ($3.11) per share in the next year.


This page (NASDAQ:MAZE) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners